Literature DB >> 18533762

The use of atypical antipsychotics in pediatric bipolar disorder.

Kiki D Chang1.   

Abstract

Diagnosis of bipolar disorder in children and adolescents is increasing, and the early-onset form of bipolar disorder usually carries more morbidity than later-onset forms. Patient education and psychotherapeutic and psychosocial interventions should be used in conjunction with carefully planned medication regimens. Recent data support the use of atypical antipsychotics for manic or mixed states in children and adolescents. However, more information is needed about long-term treatment of mania, treatment of bipolar depression, and treatment of comorbid psychiatric conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18533762

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  11 in total

1.  The dopamine dilemma: using stimulants and antipsychotics concurrently.

Authors:  Jason Yanofski
Journal:  Psychiatry (Edgmont)       Date:  2010-06

Review 2.  Pharmacotherapy of bipolar disorder in children and adolescents: recent progress.

Authors:  Jonathan C Pfeifer; Robert A Kowatch; Melissa P DelBello
Journal:  CNS Drugs       Date:  2010-07       Impact factor: 5.749

3.  Risperidone and divalproex differentially engage the fronto-striato-temporal circuitry in pediatric mania: a pharmacological functional magnetic resonance imaging study.

Authors:  Mani N Pavuluri; Alessandra M Passarotti; Jacklynn M Fitzgerald; Ezra Wegbreit; John A Sweeney
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-12-23       Impact factor: 8.829

4.  Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder.

Authors:  Robert L Findling; Idil Cavuş; Elizabeth Pappadopulos; Douglas G Vanderburg; Jeffrey H Schwartz; Balarama K Gundapaneni; Melissa P DelBello
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-10-10       Impact factor: 2.576

5.  A brief motivational intervention for preventing medication-associated weight gain among youth with bipolar disorder: treatment development and case report.

Authors:  Tina R Goldstein; Benjamin I Goldstein; Michael B Mantz; Bridget Bailey; Antoine Douaihy
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-06       Impact factor: 2.576

Review 6.  Atypical antipsychotics for acute manic and mixed episodes in children and adolescents with bipolar disorder: efficacy and tolerability.

Authors:  Manpreet K Singh; Terence A Ketter; Kiki D Chang
Journal:  Drugs       Date:  2010-03-05       Impact factor: 9.546

7.  The emerging modern face of mood disorders: a didactic editorial with a detailed presentation of data and definitions.

Authors:  Konstantinos N Fountoulakis
Journal:  Ann Gen Psychiatry       Date:  2010-04-12       Impact factor: 3.455

8.  Early exposure to haloperidol or olanzapine induces long-term alterations of dendritic form.

Authors:  Douglas O Frost; Stephanie Cerceo Page; Cathy Carroll; Bryan Kolb
Journal:  Synapse       Date:  2010-03       Impact factor: 2.562

Review 9.  Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis.

Authors:  Noor B Almandil; Ying Liu; Macey L Murray; Frank M C Besag; Katherine J Aitchison; Ian C K Wong
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

10.  Post-drug consequences of chronic atypical antipsychotic drug administration on the ability to adjust behavior based on feedback in young monkeys.

Authors:  Dorothy J Mandell; Alan Unis; Gene P Sackett
Journal:  Psychopharmacology (Berl)       Date:  2011-01-08       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.